Medtronic gets FDA approval for Brainsense device in Parkinson's patients
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
Medtronic Explores Options to Optimize Manufacturing Operations Amid Trump's Tariff Threats
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...
Parkinson’s Patients Have a New Way to Manage Their Symptoms
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
Medscape21h
FDA OKs First Adaptive DBS System for Parkinson’s Disease
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
We are party agnostic: Medtronic CTO, on weathering geo-political storms
Medtronic's agnostic approach to global challenges, including tariffs and AI, ensures success and innovation in healthcare ...
GlobalData on MSN22h
FDA approves Medtronic’s brain stimulation system for Parkinson’s
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
J&J’s potential neurovascular exit: implications for market dynamics
The neurovascular market, estimated at $4.2bn in 2024 by GlobalData, is becoming increasingly specialised and competitive.
devdiscourse3h
Healthcare Dynamics: Challenges and Innovations Amid Global Shifts
A series of important developments in the healthcare sector includes Medtronic adapting to tariff threats, Hims & Hers facing ...
Pharm Exec20h
FDA Approves Medtronic’s BrainSense Adaptive Deep Brain Stimulation for Parkinson Disease
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...
Investor's Business Daily on MSN42m
IBD Rating Upgrades: Medtronic Shows Improved Price Strength
In a welcome move, Medtronic saw its Relative Strength Rating improve from 67 to 73 on Tuesday. Please watch the video at Investors.com - How To Buy Stocks: Do You Know Your Stock's Personality Type?